Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

6.32
-0.1200-1.86%
Post-market: 6.320.00000.00%16:04 EDT
Volume:14.81K
Turnover:92.77K
Market Cap:11.40M
PE:-0.43
High:6.45
Open:6.45
Low:6.10
Close:6.44
52wk High:41.80
52wk Low:5.01
Shares:1.80M
Float Shares:1.44M
Volume Ratio:0.22
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.7963
EPS(LYR):-66.9021
ROE:-141.59%
ROA:-56.41%
PB:0.87
PE(LYR):-0.09

Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:11 AM

Reuters
·
Feb 17

Quoin Pharmaceuticals Files Initial Beneficial Ownership Statement for Stonepine Capital Management

Reuters
·
Feb 03

Quoin Pharmaceuticals Submits QRX003 for Orphan Drug Designation and Fast Track Review in Japan

Reuters
·
Jan 28

Quoin announces submission to Japanese MHLW for ODD for QRX003

TIPRANKS
·
Jan 27

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application for QRX003 in Saudi Arabia

Reuters
·
Jan 20

ADRs Close Lower; Quoin Pharmaceuticals Ltd. Declines 36%

Dow Jones
·
Dec 06, 2025

Top Premarket Decliners

MT Newswires Live
·
Dec 05, 2025

Quoin Pharmaceuticals Approves New Stock Option Agreements

TIPRANKS
·
Nov 18, 2025

Quoin Pharmaceuticals Unveils New Equity Incentive Plan for Executives and Directors

Reuters
·
Nov 18, 2025

Quoin Pharmaceuticals Achieves Key Milestone in Rapamycin Delivery

TIPRANKS
·
Nov 12, 2025

Quoin Pharmaceuticals Achieves Target Rapamycin Loadings in Topical Delivery Technologies

Reuters
·
Nov 11, 2025

Quoin Pharmaceuticals Ltd reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06, 2025

Quoin Pharmaceuticals reports Q3 EPS ($6.71) vs. ($16.29) last year

TIPRANKS
·
Nov 06, 2025

Quoin Pharmaceuticals sees cash runway into 2027

TIPRANKS
·
Nov 06, 2025

Quoin Pharmaceuticals Q3 EPS $(6.71) Misses $(6.50) Estimate

Benzinga
·
Nov 06, 2025

Press Release: Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results

Dow Jones
·
Nov 06, 2025

Quoin Pharmaceuticals Ltd expected to post a loss of $4.98 a share - Earnings Preview

Reuters
·
Nov 04, 2025

Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025

GlobeNewswire
·
Oct 30, 2025

Analysts Are Bullish on Top Healthcare Stocks: Quoin Pharmaceuticals (QNRX), Fulcrum Therapeutics (FULC)

TIPRANKS
·
Oct 30, 2025

Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study

GlobeNewswire
·
Oct 28, 2025